OCTOCAINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Octocaine, and when can generic versions of Octocaine launch?
Octocaine is a drug marketed by Septodont and is included in one NDA.
The generic ingredient in OCTOCAINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for OCTOCAINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 112 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OCTOCAINE at DailyMed |
Recent Clinical Trials for OCTOCAINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
National Taiwan University Hospital | N/A |
King Abdulaziz University | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for OCTOCAINE
US Patents and Regulatory Information for OCTOCAINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Septodont | OCTOCAINE | epinephrine; lidocaine hydrochloride | INJECTABLE;INJECTION | 084048-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Septodont | OCTOCAINE | epinephrine; lidocaine hydrochloride | INJECTABLE;INJECTION | 084048-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |